Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6797276
SERIAL NO

09257188

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A transcutaneous immunization system where the topical application of an adjuvant and an antigen or nucleic acid encoding for an antigen, to intact skin induces a ystemic or mucosol antibody response. The immune response so elicited can be enhanced by physical or chemical skin penetration enhancement.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY1400 DEFENSE PENTAGON WASHINGTON DC 20301-1400

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alving, Carl R Bethesda, MD 45 1013
Glenn, Gregory M Cabin John, MD 69 1141

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation